Trent Limited Posts Rs. 1,021.42 Crore Net Profit in H1 FY2026-27 on Rs. 11,453.94 Crore Revenue
Company reports unaudited standalone financial results for Q2 and H1 ending September 30, 2026, with Board approval on October 29, 2026
Trent Limited announced its unaudited standalone financial results for the quarter and six months ended 30th September 2026, posting a net profit of Rs. 1,021.42 crore and total income of Rs. 11,518.27 crore for H1 FY 2026-27. The results, approved by the Board on 29th October 2026, include detailed operational and financial metrics revealing stable performance compared to previous periods.
Trent Limited
Financial Results
Trent Limited reported a net profit of Rs. 1,021.42 crore for the six months ended 30th September 2026, based on unaudited standalone financial results approved by its Board on 29th October 2026. Total income for the period reached Rs. 11,518.27 crore, reflecting the company's operational scale.
For the quarter ended 30th September 2026, Trent Limited generated revenue from operations of Rs. 5,787.64 crore and total income of Rs. 5,821.79 crore. Expenses included Rs. 3,723.48 crore for purchase of stock-in-trade and Rs. 390.85 crore for employee benefits.
The company recorded Profit before tax of Rs. 644.89 crore for Q2 and Rs. 1,346.71 crore for H1 FY 2026-27. Following tax expenses of Rs. 325.29 crore for the half-year, net profit stood at Rs. 1,021.42 crore.
Earnings per share (face value Re. 1) were Rs. 9.18 for the quarter and Rs. 19.16 for the six-month period. The company maintained a debt equity ratio of 0.26 as at 30th September 2026.
The stand-alone financial statements adhere to Indian Accounting Standards and were reviewed by Deloitte Haskins & Sells LLP, with no material misstatements reported.
Highlights
- Net profit for H1 FY 2026-27: Rs. 1,021.42 crore
- Total income for H1 FY 2026-27: Rs. 11,518.27 crore
- Revenue from operations for Q2 FY 2026-27: Rs. 5,787.64 crore
- Earnings per share (basic) for H1 FY 2026-27: Rs. 19.16
- Debt equity ratio at 0.26 as of 30th September 2026
- Board approved these results on 29th October 2026
Key Data Snapshot
What happened
- Trent Limited announced its unaudited standalone financial results for Q2 and H1 FY 2026-27 ending 30th September 2026.
- The Board approved these results on 29th October 2026.
- The review was carried out by Deloitte Haskins & Sells LLP, confirming no material misstatements in the financial statements.
Financial performance
- Net profit was Rs. 489.65 crore for Q2 and Rs. 1,021.42 crore for H1 FY 2026-27.
- Revenue from operations for Q2 was Rs. 5,787.64 crore and Rs. 11,453.94 crore for H1 FY 2026-27.
- Profit before tax stood at Rs. 644.89 crore for Q2 and Rs. 1,346.71 crore for H1 FY 2026-27.
- Earnings per share (Basic) were Rs. 9.18 for Q2 and Rs. 19.16 for H1 FY 2026-27.
- Expenses included purchase of stock-in-trade at Rs. 3,723.48 crore for Q2 and Rs. 6,736.20 crore for H1.
- The debt equity ratio reduced to 0.26 as of 30th September 2026 from previous quarters.
Regulatory and governance context
- Results comply with SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, including Regulations 30, 33(3), and 52(1).
- The financial results comply with Indian Accounting Standard 34 (Ind AS 34) for interim financial reporting.
- Deloitte Haskins & Sells LLP reviewed the financial statements and issued Limited Review Reports dated 29th October 2026.
Highlights
- Net profit for H1 FY 2026-27: Rs. 1,021.42 crore
- Total income for H1 FY 2026-27: Rs. 11,518.27 crore
- Revenue from operations for Q2 FY 2026-27: Rs. 5,787.64 crore
- Earnings per share (basic) for H1 FY 2026-27: Rs. 19.16
- Debt equity ratio at 0.26 as of 30th September 2026
- Board approved these results on 29th October 2026
Disclosures
- SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 - Regulations 30, 33(3), and 52(1)
- Indian Accounting Standard 34 (Ind AS 34)
More News on Financial Results
View allLatest corporate announcements and market updates in Financial Results.
Indegene Limited Announces Unaudited Consolidated and Standalone Results for Q2 and H1 Ending September 30, 2026
Indegene Limited approved its unaudited consolidated and standalone financial results for the second quarter and half year ended September 30, 2026, alongside approving allotments under RSU and ESOP schemes and key personnel resignations during its board meeting on October 29, 2026.
Read Full StoryAlivus Life Sciences Posts ₹3,568 Million Net Profit in First Half of FY2026, Q2 Net Profit at ₹1,967 Million
Alivus Life Sciences Limited has reported its unaudited financial results for the second quarter and half year ended September 30, 2026, posting a net profit of ₹1,967 million for the quarter and ₹3,568 million for the half year, supported by revenue growth.
Read Full StoryTimken India Limited Achieves Rs 2,311.94 Million Net Profit for First Half of FY 2026-27
Timken India Limited reported a net profit after tax of Rs 2,311.94 million for the half year ended September 30, 2026, with revenue from operations totaling Rs 18,983.82 million, as per its unaudited standalone financial results approved by the Board on October 29, 2026.
Read Full Story